bacterial+pathogenesis

Upload: raghavan89

Post on 03-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 Bacterial+Pathogenesis

    1/84

    Bacterial Pathogenesis

    Kunle Kassim, PhD, MPH

    Professor, MicrobiologyAugust, 2010

  • 7/29/2019 Bacterial+Pathogenesis

    2/84

    URGENT!!!!

    It is important for you to review the lecture

    powerpoint on Host/Bacteria Interactions

    from first yearbefore coming to class forthis lecture.

  • 7/29/2019 Bacterial+Pathogenesis

    3/84

    Objectives

    Review the diversity and significance of bacterial flora in the maintenance ofimmunity

    Review the various types of flora distruption and health consequences to the host.

    Review determinants of pathogenicity

    Discuss the roles of endotoxin and exotoxins in specific instances of bacterial

    pathogenesis Illustrate invasiveness and dissemination of bacterial pathogenesis with Salmonella

    and Shigella pathogenesis.

    Discuss the different ways that bacterial pathogens exert damage and injury to thehost, using cystic fibrosis, lyme disease and bacterial urethritis as illustrations

    Present the different types of host defenses, including the constitutive elements ofinnate and adaptive immunity, humoral and cellular immunity, inflammatory and

    acute phase responses. Describe the emerging patterns and serious significance of nosocomial infections

    Discuss the nature, usefulness and schedule of bacterial vaccines, particularly inpreventing childhood infectious diseases.

  • 7/29/2019 Bacterial+Pathogenesis

    4/84

    Normal Bacterial Flora

    Bacterial Virulence Factors

    Mechanisms of Pathogenicity

    Host Defense Mechanisms

    Selected Bacterial Diseases

    (Review lecture materials on Bacteria/Host

    Intreactions)

  • 7/29/2019 Bacterial+Pathogenesis

    5/84

    Distruption of Normal Flora

    Trauma

    - appendix rupture, dental extraction, auto

    accidents, gun violence Flora displacement/contamination

    - UTI, bacterial vaginosis

    Excessive antibiotic use- vaginal candidaisis, pseudomembranous

    colitis by Clostridium difficile

  • 7/29/2019 Bacterial+Pathogenesis

    6/84

    Distruption of Normal Flora

    UTI

    Tumors

    Bladder incontinence Ureteric reflux

    Poor hygiene

    E. coli infections

  • 7/29/2019 Bacterial+Pathogenesis

    7/84

    Determinants of Pathogenicity

    Ports of entry

    Modes of transmission

    Bacterial adherence

    Invasiveness/Dissemination

    Pathological damage

    Endotoxin / Exotoxins

    Fever / Disease onset

    Host defenses

    Evasion of host defenses

    Siderophore production Plasmids

    Bacterial vaccines

    (Review last years lecture materials on Bacteria/Host Interactions)

  • 7/29/2019 Bacterial+Pathogenesis

    8/84

    Toxins Endotoxin (Lipid A component ofLPS)

    -Unlike exotoxins, lipid A is not antigenic and cannot beconverted to a toxoid; responsible for gram negativesepticemia, with a fatality rate of 25-50 percent in USA

    Exotoxins

    -most are polypeptides, are antigenic and can be convertedto toxoids

  • 7/29/2019 Bacterial+Pathogenesis

    9/84

  • 7/29/2019 Bacterial+Pathogenesis

    10/84

    Endotoxin and Septicemia

    Fever

    Activation of coagulation process

    Depression of RES

    Vascular collapse

  • 7/29/2019 Bacterial+Pathogenesis

    11/84

  • 7/29/2019 Bacterial+Pathogenesis

    12/84

    Lipid A, Coagulation and RES

    Lipid A activates clotting mechanism, withformation of fibrin

    Fibrin may clog small blood vessels,causing intravascular coagulation, followedby shock

    Lipid A may inhibit macrophages fromdegrading fibrin polymers trapped in bloodvessels

  • 7/29/2019 Bacterial+Pathogenesis

    13/84

    Lipid A and Vascular Collapse

    Lipid A activates macrophages to release

    TNF-, which causes increased vascular

    permeability and dilatation

    This causes low blood pressure

    (hypotension), impairs blood flow to vital

    organs (kidneys, liver, lung, brain),followed by shock, multiple organ failure

    and death

  • 7/29/2019 Bacterial+Pathogenesis

    14/84

  • 7/29/2019 Bacterial+Pathogenesis

    15/84

    Neisseria species

    Are all gram negative cocci

    Oxidase, catalase positive

    Multiply intracellularly

    Neisseria meningitidis

    Neisseria gonorrhea Neisseria sicca

  • 7/29/2019 Bacterial+Pathogenesis

    16/84

    Neisseria meningitidis

    Gram negative diplococci

    Infection from aerosol transmission in close contacts

    Polysacharide capsule is antiphagocytic

    LPS, capsule and sIgA protease are major virulence factors

    Meningitis, fever, pneumonia, meningococcemia withhemorrhagic lesions are major clinical manifestations

    Prevented by immunization with polysacharide-protein

    conjugate vaccine

  • 7/29/2019 Bacterial+Pathogenesis

    17/84

    Meningococcemia

  • 7/29/2019 Bacterial+Pathogenesis

    18/84

    Death from Neisseria septicemia and

    meningitis

  • 7/29/2019 Bacterial+Pathogenesis

    19/84

    Neisseria urethritis

    Gonorrhea with

    purulent discharge

    Disseminatedinfections via blood

    to skin, joints

    Ophthalmianeonatorium

    (acquired eye

    infection)

  • 7/29/2019 Bacterial+Pathogenesis

    20/84

    Complications of Gonococcal

    Infection Skin lesion

    Septic arthritis

    Ophthalmia

    neonatorium

  • 7/29/2019 Bacterial+Pathogenesis

    21/84

    Neisseria gonococcus / Chlamydia

    Urethritis Differentiation

  • 7/29/2019 Bacterial+Pathogenesis

    22/84

    Bacterial Classification and Pathogenesis

  • 7/29/2019 Bacterial+Pathogenesis

    23/84

    Meningitis

    (Strep pneumo, H. influenzae, N. meningitidis)

  • 7/29/2019 Bacterial+Pathogenesis

    24/84

    Exotoxins

    Enzymatic lysis

    alpha toxinClostridium perfringes

    Pore formation

    alpha toxinStaph aureus

    Protein synthesis inhibition

    diphtheria & shigella toxins

    Nerve-muscle transmission-inhibition

    tetanus toxin-spastic paralysis

    botulinum toxin-flaccid paralysis

  • 7/29/2019 Bacterial+Pathogenesis

    25/84

    Modes of Action of Selected Exotoxins

  • 7/29/2019 Bacterial+Pathogenesis

    26/84

    Cholera

    (Vibrio cholerae)

  • 7/29/2019 Bacterial+Pathogenesis

    27/84

    Clostridium and Bacillus

    Identification of species based on spore location

    and oxygen metabolism:

    - C. tetanus- C. botulinum

    - C. perfringes

    - C. difficile- B. anthracis

    - B. cereus

  • 7/29/2019 Bacterial+Pathogenesis

    28/84

    Spore Location for Species ID

  • 7/29/2019 Bacterial+Pathogenesis

    29/84

    Tetanus

    (Clostridium tetani and skeletal muscle flexion)

  • 7/29/2019 Bacterial+Pathogenesis

    30/84

    Bacillus anthracis

    (potential bioterrorism agent, 2001)

  • 7/29/2019 Bacterial+Pathogenesis

    31/84

    Gram Stain ofB. anthracis in Lung

    Exudate of an Anthrax Patient

  • 7/29/2019 Bacterial+Pathogenesis

    32/84

    Bacterial Classification and Pathogenesis

  • 7/29/2019 Bacterial+Pathogenesis

    33/84

    Staphylococcus and Streptococcus

    Tetrad cocci of

    Staph aureus

    (MRSA)

    String-like cocci of Streppneomoniae/ Strep

    viridans Enterococcus faecalis

    MDR-Strep/Entero

  • 7/29/2019 Bacterial+Pathogenesis

    34/84

    Staphylococcus aureus

    Diseases

    Toxin-mediated food poisoning, toxic shock syndrome;cutaneous impetigo, folliculitis, wound infections,

    pneumonia, osteomyelitis, septic arthritisVirulence Factors

    Capsule, protein A, cytotoxins/hemolysins, enterotoxins,exfoliative toxin; coagulase/catalase/beta-lactamaseenzymes

    Methycillin-resistant Staph aureus (MRSA)

    (antibiotic resistant strain, serious problem in hospitals, inthe US military, among athletes)

  • 7/29/2019 Bacterial+Pathogenesis

    35/84

    Scalded skin syndrome due to

    Staphylococcus aureus exotoxin

  • 7/29/2019 Bacterial+Pathogenesis

    36/84

    Gram Stain ofStrep viridans in

    exudate of cardiac valves

  • 7/29/2019 Bacterial+Pathogenesis

    37/84

    Bacterial endocarditis

    from a dental extraction

  • 7/29/2019 Bacterial+Pathogenesis

    38/84

  • 7/29/2019 Bacterial+Pathogenesis

    39/84

    E. coli Pathogenesis

    Diseases

    Gastroenteritis, bacteremia, UTI, cystitis,

    pyelonephritis, neonatal meningitis,intraabdominal infections

    Virulence Factors

    Capsule, LPS, shiga toxins, hemolysins,siderophores (enterobactin, aerobactin),

    R-plasmid

  • 7/29/2019 Bacterial+Pathogenesis

    40/84

  • 7/29/2019 Bacterial+Pathogenesis

    41/84

  • 7/29/2019 Bacterial+Pathogenesis

    42/84

    Invasiveness / Dissemination

    Exotoxins and Extracellular enzymes

    Extracellular enzymes

    Hyaluronidase dissolves connective tissue Collagenase hydrolyses muscle connective tissue

    Streptokinase lyses blood clots

    Phospholipases damage cell membranes

    Lecithinase damages cell membranes

    Staphylokinase (fibrinolysin) dissolves fibrin clots

    _ Hemolysins lyse erythrocytes and white blood cells

  • 7/29/2019 Bacterial+Pathogenesis

    43/84

    Shigella/Salmonella Invasive &

    Dissemination Mechanisms Shigella

    Invades M cells w 4 invasionproteins (IpaA,B,C,D)

    Replicates in host cellcytoplasm

    Induces apoptosis ofphagocytes

    Produces cytotoxin (60sribosome protein inhibitor)

    Invades deeper tissues, but notblood circulation

    Causes diarrhea, dysentery

    Low infective dose (100 cells)

    Salmonella

    Invades w invasion proteins

    Replicates in acidic host cellvacuole

    Replicates and transported bymacrophages in bloodcirculation

    Invades other systemic organs,but not deeper GI tissues

    Causes diarrhea, enteric fever High infective dose (>I million

    cells)

  • 7/29/2019 Bacterial+Pathogenesis

    44/84

    Salmonella/Shigella Invasive &

    Mechanisms

  • 7/29/2019 Bacterial+Pathogenesis

    45/84

    Cystic Fibrosis

    Genetically inherited disorder occurring in 1 of

    2500 live Caucasian births

    Caused by pancreatic insufficiency, abnormalsweat electrolyte concentrations, viscid bronchial

    secretions

    Bronchial secretions lead to stasis in lungs and

    disposition to infections ( Staph aureus, H.influenzae, Pseudomonas aeruginosamost

    virulent and antibiotic resistant) and pneumonia

  • 7/29/2019 Bacterial+Pathogenesis

    46/84

    Cystic Fibrosis

  • 7/29/2019 Bacterial+Pathogenesis

    47/84

    Lyme Disease

  • 7/29/2019 Bacterial+Pathogenesis

    48/84

    Lyme Disease

    Caused by Borrelia burgdorferi

    Transmitted by hard ticks (Ixodes species)

    Human infections most prevalent in summer months in

    Europe and USA Accompanied by fever, headache, myalgia,lymphadenopathy, skin lesions (erythema chronicummigrans)

    Neurological complications (meningitis, encephalitis,

    peripheral neuropathy) Cardiological (heart block, myopericarditis)

    Arthralgia, arthritis (immune complex mediated)

    Treatable with penicillin or tetracycline at early stage

  • 7/29/2019 Bacterial+Pathogenesis

    49/84

    Lyme Disease

    (rash of erythema chronicum/

    inflammation)

  • 7/29/2019 Bacterial+Pathogenesis

    50/84

    Lyme Disease

  • 7/29/2019 Bacterial+Pathogenesis

    51/84

    Host Defenses

    Barriers to Infection

    Innate and adaptive immunity

    Humoral and cellular immunity Phagocytosis

    Complement activation

    Inflammation Acute phase response

    Hypersensitivity Reactions

  • 7/29/2019 Bacterial+Pathogenesis

    52/84

    Barriers to Infection

  • 7/29/2019 Bacterial+Pathogenesis

    53/84

    Innate and Adaptive Immunity

  • 7/29/2019 Bacterial+Pathogenesis

    54/84

    Antibody Responses to Infections

  • 7/29/2019 Bacterial+Pathogenesis

    55/84

    Various Roles of Macrophages

  • 7/29/2019 Bacterial+Pathogenesis

    56/84

    Macrophage and Neutrophil

  • 7/29/2019 Bacterial+Pathogenesis

    57/84

    Host immune responses to bacterial

    infections

  • 7/29/2019 Bacterial+Pathogenesis

    58/84

    Cytokine and Antibody Networks in

    Bacterial Infections

  • 7/29/2019 Bacterial+Pathogenesis

    59/84

    Inflammation

    Consequence of a microbial infection

    Recruitment of inflammatory cells (neutrophils,macrophages, basophils, eosinophils) andendogenous mediators (complement,

    prostaglandin E2) to sites of infection

    Production of inflammatory cytokines ( IL-1,

    IL-6, TNF-) to induce acute-phase response May be accompanied by antigen neutralization

    and cytotoxicity

  • 7/29/2019 Bacterial+Pathogenesis

    60/84

    Stages of Inflammation

    Tissue Damage

    Vasodilation Exudation

    Endothelial adherence

    Diapedes (phagocytemigration)

    Tissue repair

  • 7/29/2019 Bacterial+Pathogenesis

    61/84

    Inflammation from Lyme Disease

    (rash of erythema chronicum)

  • 7/29/2019 Bacterial+Pathogenesis

    62/84

    Induction of acute phase proteins in

    response to an infection

  • 7/29/2019 Bacterial+Pathogenesis

    63/84

    Acute Phase Response

    Also a response to infection as with inflammation

    Triggered by IL-1, IL-6, TNF-, inflammation,prostaglandin E2, interferon

    Induce production of acute phase proteins(C-reactive protein, complement components,coagulation proteins)

    Reinforce innate defenses (complement activation,

    phagocytosis) against infection, but excessiveproduction during sepsis by LPS can lead to shock

    What are other acute phase responses???

  • 7/29/2019 Bacterial+Pathogenesis

    64/84

    Hypersensitivity Reactions to

    Bacterial Infections

  • 7/29/2019 Bacterial+Pathogenesis

    65/84

    Antigenic Variation

    Periodic changes ofsurface antigens by theorganism allows it to

    bypass and not beaffected by the hostimmune responses.This occurs in HIV

    infection, Lymedisease andtrypanosomiasis.

  • 7/29/2019 Bacterial+Pathogenesis

    66/84

    Stages of a Disease

  • 7/29/2019 Bacterial+Pathogenesis

    67/84

    Hospital-acquired (Nosocomial)

    Infections

  • 7/29/2019 Bacterial+Pathogenesis

    68/84

    Pennsylvania 2004 Nosocomial

    Infections

  • 7/29/2019 Bacterial+Pathogenesis

    69/84

    Sites of Antibiotic Activities

  • 7/29/2019 Bacterial+Pathogenesis

    70/84

  • 7/29/2019 Bacterial+Pathogenesis

    71/84

    Immunization

    Passive maternal antibodies thr placenta

    and mothers milk

    Active -- natural exposure to microbes

    - exposure to vaccines

    Live vaccineattenuated Mycobacteriumbovis

    Inactivated toxoidtetanus vaccine

    Inactivated killedtyphoid vaccine

    Subunit capsular polysacharides (poor immunogens)

    -Hemophilus influenzae b, Neisseria meningitidis, Streptococcuspneumoniae Salmonella typhi

    Conjugate vaccinespolysacharide units conjugated to proteinmolecules

  • 7/29/2019 Bacterial+Pathogenesis

    72/84

    Childhood Immunization Schedule

  • 7/29/2019 Bacterial+Pathogenesis

    73/84

  • 7/29/2019 Bacterial+Pathogenesis

    74/84

    Case Studies

  • 7/29/2019 Bacterial+Pathogenesis

    75/84

    CASE 1: URINARY TRACT INFECTION

    Mr. Hamilton, a 69-year old man, underwent a transurethral

    prostatectomy for cancer of the prostate. Because of concern about

    postoperative bleeding during urination, the surgeons placed a

    Foley catheter into his bladder. Three days later, Mr. Hamilton

    developed a urinary tract infection with low-grade fever, some

    pain, and pyuria. Laboratory cultures yielded 3 x 105 colonies ofEscherichia coli per ml of urine. The organisms were resistant to

    all tested antibiotics except for aminoglycosides. Within 2 days,

    Mr. Hamilton developed bacteremia with hypotension and shock.

    His doctor eventually controlled his bacteremia with gentamycintherapy.

  • 7/29/2019 Bacterial+Pathogenesis

    76/84

    Questions (#1)

    I. What was the source of Mr. Hamilton'sinfection?

    2. What bacterial component induced his fever,

    hypotension and shock and how?

    3. List three characteristics of aminoglycosidesand their modes of action.

    4. What other organism could have been isolatedfrom his infection site? Give reasons for yourchoice of organism.

    CASE 2: NOSOCOMIAL WOUND INFECTION

  • 7/29/2019 Bacterial+Pathogenesis

    77/84

    CASE 2: NOSOCOMIAL WOUND INFECTION

    Ms. Wilson, an 85-year-old woman with rheumatic heart disease, underwent a mitral

    valve replacement along with surgery for a coronary artery bypass graft. Her

    postoperative course was complicated by bleeding in the mediastinum, which

    required more surgery .She did well after these operations and was discharged after

    12 days. Three weeks later, Ms. Wilson, noticed some purulent drainage along the

    wound site on her chest. She continued to have pain but did not tell her family,

    assuming that the pain was related to her healing process. When she returned to see

    the surgeon I month later, she reported her pain and low-grade fever. The surgeonnoted that there was considerable drainage at the wound site. Probing the wound, he

    noticed a lot of pus. Ms. Wilson was hospitalized again for radical debridement

    (cleaning) of her chest wound. Cultures of the pus yielded Staphylococcus

    epidermidis. She was treated intravenously with vancomycin for 6 weeks and her

    wound was debrided, with the wires in her sternum removed. At the end of thisperiod, she required a plastic surgical procedure and a muscle flap to close the

    wound. After 2 more months of hospitalization, she was discharged and continued

    her convalescence at home.

  • 7/29/2019 Bacterial+Pathogenesis

    78/84

    Questions (#2)

    I. Describe the bacterial pathogenesis of rheumatic heartdisease., including the organisms that may be associatedwith its causation.

    2. What was the source of her postoperative wound

    infection? 3 .What is the mode of action of vancomycin and why was

    it the drug of choice for Mrs. Wilson's

    wound infection?

    4. In the absence of vancomycin, what other antibiotic(s)would you choose to clinically manage the woundinfection? Describe its mode of action.

  • 7/29/2019 Bacterial+Pathogenesis

    79/84

    Case # 4

    Simo da Silva, 36-year-old male resident of New Jersey, developed joint and muscle pains

    and an expanding erythematous skin lesion on his left leg shortly after his summer vacation.

    A week later, he started experiencing severe headache, neck stiffness and photophobia. He

    also noticed multiple secondary annular skin lesions three weeks later. Blood analysis

    reveled a high titer of IgM antibodies against a Gram negative spirochete, but the IgG

    response was negative. Ten months after the resolution of the initial symptoms, Mr .da Silvahad severe neuritic pain on the skin of his abdomen within the distribution of the T8 through

    T 11 dermatomes. This symptom was followed by intermittent joint pains, which occurred

    in one joint at a time for several days, followed by longer pain- free periods. During the

    second year of illness, the patient had a sudden onset of severe swelling of one knee and

    then the other. Synovial fluid analysis revealed numerous white cells, and his antibody

    response was high for IgG and low for IgM. His immunogenic profile showed that he had

    Ill-A-DR4 and Ill-A-DR+ specificities. The swelling of the knees remained for about one

    year, but then subsided.

  • 7/29/2019 Bacterial+Pathogenesis

    80/84

    Questions (#4)

    I. How did Mr. da Silva acquire the spirochete infection and what isyour identification of the organism?

    2. What antibiotics would you use to treat his initial and late diseases?Is this a case of acute or chronic infection or disease?

    3. What bacterial and immune factors are responsible for hisintermittent joint pains and knee swelling?

    4. Explain the initial high IgM and no IgG titers in the early stage ofthe disease and the low IgM and high IgG titers in Mr .da Silva latedisease stage.

    5. What type of white cells ( T cells, B cells, neutrophils, basophils,macrophages ) were found in the synovial fluid?

    6. What does his immunologic profile ofHLA-DRA4 and HLA-DR2specificities mean?

  • 7/29/2019 Bacterial+Pathogenesis

    81/84

    Case #5

    Three young males were brought to HowardUniversity Hospital Emergency Clinic over thecourse of two days. They were diagnosed with

    bacterial meningitis, but their cerebrospinal fluid(csf) cultures yielded three different organisms.They were all lethargic with fevers of 101 to

    104o F, white blood cell (wbc) counts of over15,000 cells/l, mostly neutrophils. One of the

    bacterial isolates was identified as Streptococcuspneumoniae, the second asHemophilus influenzaetybe b and the third asNeisseria meninigitidis.

  • 7/29/2019 Bacterial+Pathogenesis

    82/84

    Questions (#5)

    What bacterial culture chracteristics and laboratory methods wereused to separately identify the three organisms?

    What is the pathogenic bacterial structure that is common to the threeorganisms and how is its composition different for each organism?

    Describe the pathway(s) that were taken by the organisms to get intothe patients csf.

    What are the epidemiological characteristics of the meningitis causedby each organism?

    What antibiotics of choice would you use to treat the patients? Givereasons for your choice.

    What are the modes of action for your choice of antibiotics? What types of resistance mechanism may be used by each of theorganisms to inhibit the activity of your selected antibiotics?

  • 7/29/2019 Bacterial+Pathogenesis

    83/84

    Home-Work Exercise

    List organisms that may be associated with the following conditions

    1. Bacteremia

    2. Endocarditis

    3. Meningitis

    4. Pharyngitis 5. Pneumonia

    6. Conjunctivitis

    7. lntra-abdominal abscess

    8. Gastroenteritis

    9. Urinary Tract infections 10. lmpetigo

    11. Cellulitis

    12. Sepsis

  • 7/29/2019 Bacterial+Pathogenesis

    84/84

    Reading References

    Chapters 9-13, 18 , 47 in Medical Microbiology,

    6th edition by Patrick Murray et al, Mosby, Inc.,

    2009

    Chapters 8 -10 in Medical Microbiology, 3rd

    edition by Cedric Mims, et al, Mosby, Inc., 2004.

    Chapters 6, 7, 8 and 9 in Mechanisms of Microbial

    Diseases, 3rd edition by Moselio Schaechter, etal, William & Wilkins, 1998.